Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Change in Receivables (2019 - 2025)

Evolus' Change in Receivables history spans 7 years, with the latest figure at $4.8 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 25.15% year-over-year to $4.8 million; the TTM value through Dec 2025 reached $11.5 million, down 41.29%, while the annual FY2025 figure was $11.5 million, 41.29% down from the prior year.
  • Change in Receivables reached $4.8 million in Q4 2025 per EOLS's latest filing, down from $4.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $9.5 million in Q2 2024 to a low of -$1.3 million in Q1 2021.
  • Average Change in Receivables over 5 years is $2.8 million, with a median of $2.4 million recorded in 2023.
  • Peak YoY movement for Change in Receivables: tumbled 153.32% in 2021, then surged 2435.76% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $1.5 million in 2021, then grew by 21.09% to $1.8 million in 2022, then crashed by 91.44% to $151000.0 in 2023, then soared by 2435.76% to $3.8 million in 2024, then grew by 25.15% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for EOLS's Change in Receivables are $4.8 million (Q4 2025), $4.9 million (Q3 2025), and $958000.0 (Q2 2025).